Interestingly, two of the RNase L disease‐causing mutations, G59S and E265*, were previously indicated in prostate and breast cancers, suggesting that patients with these mutations are susceptible to multiple diseases (Nguyen‐Dumont et al. 2018; Rökman et al. 2002). Here, RNASEL is linked to breast carcinoma.